[1] |
REN Yuke, QU Zhe, LAI Zixuan, ZHANG Di, ZHAO Yongtian, YANG Yanwei, LI Shuangxing, HUO Guitao, ZHOU Xiaobing, LIN Zhi, GENG Xingchao.
Pharmacodynamic Evaluation of CAR-T Cell Products Based on Deep Learning Convolutional Neural Network Recognition
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 742-748.
|
[2] |
LIU Yiyu, LI Yanwen, WANG Jiao, ZHOU Wenjing, PENG Yumeng, HE Wenbin, LI Zhiyong.
Efficacy Semantic Mining and Safety Analysis of Chinese Patent Medicines for Headache
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 674-679.
|
[3] |
ZHANG Huiting, LI Youlin, LI Lei, YAN Yue, YAO Ting, LI Chunlei, SHI Qi.
Toxicity of Single-Dose and Repeated-Dose Administration of Guisha Zichuan Granules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 547-553.
|
[4] |
WANG Jiaqing, WANG Qi, LIU Tongtong, ZHANG Dongjie, NING Xiao.
Uncertainty Evaluation for the Determination of Tacrolimus Content in Human Whole Blood by UPLC-MS/MS Method
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 386-390.
|
[5] |
YANG Jingqi, XU Baohai, ZHANG Jing, JIANG Yang, SHI Fang.
Pharmacovigilance for Traditional Chinese Patent Medicines for Orthopedics
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 436-441.
|
[6] |
YANG Xuyun, SUN Yang, TIAN Chunhua, HU Zengyao.
A National Pharmacovigilance Management System in a New Era
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 276-281.
|
[7] |
WANG Han, WANG Cunxuan, LYU Xuehaiyue, ZHANG Lining, SUO Yusi, GU Zhi'en, WANG Ping, JIN Xuejing.
Chinese Patent Medicines for Preventing Myelosuppression in Adjuvant Treatment of Malignant Tumors: a Systematic Review and Network Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 169-176.
|
[8] |
ZHENG Changhui, MA Lina, HE Ting, GU Yuanyuan, ZHAO Wei, WANG Hongbin, NIU Yuanfei, FU Yao, CHEN Yanjun, CAO Junling.
Quality Evaluation and Control of Bupleuri Radix Decoction Pieces Based on ‘Shape-Chemistry-Biology' Sequential Detection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 197-205.
|
[9] |
NIE Xiaolu, ZHAO Houyu, HUO Donghui, YAN Aixia, SUN Feng, PENG Xiaoxia, NI Xin, ZHAN Siyan.
Pediatric Drug-Induced Immune Thrombocytopenia Based on Real World Data and Quantitative Structure-Activity Relationship
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 16-22.
|
[10] |
JIA Juanjuan, SUN Jiabei, ZHANG Wenzai, SUN Deyang, SHI Yaqin, HUANG Haiwei.
Biological Distribution of 99mTc-DMSA Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 47-52.
|
[11] |
YU Wenlu, ZHANG Hong.
Research Progress in Applications of Strychnine Semen in Orthopedics and Traumatology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 116-120.
|
[12] |
WANG Yijin, TANG Jing, YANG Chao, XU Kai, ZHANG Mengdie, GAO Jian, WU Xiaoli, ZHANG Yue, NIU Xiaobing, JIANG Hesong, MAO Fei, ZHOU Shan, JIANG Xi, GUO Zhongying, SUN Su'an, XU Ming, XU Zongyuan, WANG Hengbing, LI Xin, FU Guangbo.
Clinical research of submucosal low-dose gemcitabine injection combined with transurethral resection of bladder tumor in the treatment of medium-high risk non-muscle invasive bladder cancer
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1044-1050.
|
[13] |
ZHENG Li, ZHANG Kaihua, SUN Xuelin.
Pharmacological effect and clinical evaluation of tarlatamab against small cell lung cancer
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1078-1080.
|
[14] |
SUN Li, XIE Bin, XU Yanqin.
Research progress of sustained and controlled release preparations of Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 949-954.
|
[15] |
CAI Haili, ZHANG Xiaomeng, LIU Yadi, LIU Shujia, GAO Fujun, WANG Yu, ZHANG Bing.
Progress in construction and evaluation of a drug-induced cardiotoxicity model
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 765-770.
|